BRISTOL-MYERS SQUIBB COMPANY Accrued Liabilities, Current
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Accrued Liabilities, Current of $5.86 billion as of 2019-03-31, per its 10-Q filed 2019-04-25.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2019-04-25
- 2019-03-31: Accrued Liabilities, Current $5.86B.
- 2018-12-31: Accrued Liabilities, Current $6.49B.
- 2018-09-30: Accrued Liabilities, Current $5.85B.
- 2018-06-30: Accrued Liabilities, Current $5.83B.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2019-03-31 | $5.86B 10-Q · filed 2019-04-25 | |
| 2018-12-31 | $6.49B 10-Q · filed 2019-04-25 | |
| 2018-09-30 | $5.85B 10-Q · filed 2018-10-25 | |
| 2018-06-30 | $5.83B 10-Q · filed 2018-07-26 | |
| 2018-03-31 | $5.56B 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $6.01B 10-K · filed 2019-02-25 | |
| 2017-09-30 | $5.42B 10-Q · filed 2017-10-26 | |
| 2017-06-30 | $5.13B 10-Q · filed 2017-07-27 | |
| 2017-03-31 | $4.78B 10-Q · filed 2017-04-27 | |
| 2016-12-31 | $5.27B 10-K · filed 2018-02-13 | |
| 2016-09-30 | $4.96B 10-Q · filed 2016-10-27 | |
| 2016-06-30 | $4.88B 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $4.31B 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $4.74B 10-K · filed 2017-02-21 | $2.76B 10-K · filed 2016-02-12 |
| 2015-09-30 | $2.33B 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $2.10B 10-Q · filed 2015-07-23 | |
| 2015-03-31 | $1.79B 10-Q · filed 2015-04-28 | |
| 2014-12-31 | $2.46B 10-K · filed 2016-02-12 | |
| 2014-09-30 | $2.29B 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $2.20B 10-Q · filed 2014-07-24 | |
| 2014-03-31 | $2.00B 10-Q · filed 2014-04-29 | |
| 2013-12-31 | $2.15B 10-K · filed 2015-02-13 | |
| 2013-09-30 | $2.28B 10-Q · filed 2013-10-23 | |
| 2013-06-30 | $2.42B 10-Q · filed 2013-07-25 | |
| 2013-03-31 | $2.38B 10-Q · filed 2013-04-25 | |
| 2012-12-31 | $2.57B 10-K · filed 2014-02-14 | |
| 2012-09-30 | $2.76B 10-Q · filed 2012-10-24 | |
| 2012-06-30 | $2.47B 10-Q · filed 2012-07-25 | |
| 2012-03-31 | $2.57B 10-Q · filed 2012-04-26 | |
| 2011-12-31 | $2.79B 10-K · filed 2013-02-15 | |
| 2011-09-30 | $2.70B 10-Q · filed 2011-10-27 | |
| 2011-06-30 | $2.83B 10-Q · filed 2011-07-28 | |
| 2011-03-31 | $2.66B 10-Q · filed 2011-04-28 | |
| 2010-12-31 | $2.74B 10-K · filed 2012-02-17 | |
| 2010-09-30 | $2.68B 10-Q · filed 2010-10-26 | |
| 2010-06-30 | $2.39B 10-Q · filed 2010-07-22 | |
| 2010-03-31 | $2.48B 10-Q · filed 2010-04-29 | |
| 2009-12-31 | $2.79B 10-K · filed 2011-02-18 | |
| 2009-09-30 | $2.99B 10-Q · filed 2009-10-22 | |
| 2008-12-31 | $2.97B 10-K · filed 2010-02-19 | $2.94B 10-Q · filed 2009-10-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |